Repatha™ will be the only PCSK9-inhibitor on the CVS/caremark commercial formularies Provides members with access to high quality drug and helps clients better manage their specialty pharmacy spend WOONSOCKET, RI, 2015-11-24 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today that Repatha™ (evolocumab) from Amgen Inc. will be added as the only PCSK9 inhibitor on…